# imvaria

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/imvaria

- Industry: Medical Devices & Equipment
- Headquarters: Berkeley, US
- Website: www.imvaria.com
- Latest round: Seed (Apr 1, 2020)
- Investors on record: 3

## About

Based in California, US, and founded in 2019 by a team of physician-engineers from Stanford and Google, Joshua Reicher and Michael Muelly. Imvaria, Inc. operates as a developer of digital biomarkers. In January 2026, imvaria, Inc. raised an undisclosed amount of venture funding from InHealth Ventures, Cedar Crest Holdings, Labcorp Venture, and National Institutes of Health. The company's novel Digital Biomarker Platform enables non-invasive diagnostic and therapeutic patient stratification via data science and machine learning algorithm. The company will use the January 2026 funding to extend its AI-driven diagnostic services for lung diseases and increase clinician access to its tests.

## Funding rounds

- Seed, Apr 1, 2020 — Cloudstone Venture, Creative Ventures, InHealth Ventures

## Investors

- Cloudstone Venture (https://capitalatlas.ai/funds/cloudstone-venture) — Seed
- Creative Ventures (https://capitalatlas.ai/funds/creative-ventures) — Seed
- InHealth Ventures (https://capitalatlas.ai/funds/inhealth-ventures) — Seed